Suchergebnisse

Intro -- Foreword -- Acknowledgments -- Introduction: Locating the Decolonial Left -- Contents -- Notes on Contributors -- List of Figures -- List of Tables -- Grounding the Movement -- This Is Not Restoration: Notes on a Protest Slogan -- Preface -- A Brief History -- Meanings of the Slogan -- The Ideological Retreat of the Local Left -- Local Plight, Global Phenomenon -- References -- Self-Determination Through Struggle -- Between Independent Politics and the Early Pro-democracy Movement -- Localism's Contradictions -- Self-Determination Through Coalition -- References -- How to Abolish the Hong Kong Police -- The Hong Kong Police's Job Is to Protect the Establishment -- Abolition Means Democracy -- Internationalist Abolitionism-Learning from Each Other -- Challenging Assumptions of Prosecutorial Justice -- Making Abolition Possible -- From Activism to Abolition -- Abolition in Hong Kong Is Now -- References -- The Dilemma of the New Union Movement -- The Birth of the New Union Movement -- New Union Movement: Its Challenges -- The Potential of Linking Economic and "Political" Grievances -- What Should Be the Strategies Going Forward? -- References -- Decolonizing Protest Suicide: Performing Life in Hong Kong -- A Liminal State Between Life and Death -- Death Against Laam Chau -- Decolonizing the Necropolitics of Suicide -- References -- Decolonization as Egalitarian Transformation: Hong Kong's Unfinished Struggle -- Decolonization as Egalitarian Transformation -- Hong Kong After 1997: Decolonization Lite -- Toward Practices of Decolonization as Egalitarian Transformation -- References -- Material Life -- Between Liberalism and Nationalism: Hong Kong's Anti-ELAB Protests and the Right to the City -- Neoliberal Financialization of Hong Kong's Urban Space -- The Right to Hong Kong -- An Anti-Capitalist Identity? -- References.

PurposeThis study examines the effectiveness of Zero-Contact Marketing that minimizes contact between employees and consumers in marketplaces by adopting an integrated research framework of motivation theory, servicescape model and the theory of reasoned action (TRA).Design/methodology/approachThis study randomly collected 314 respondents through an online survey in May 2020 in South Korea. Structural equation modeling (SEM) assessed the overall hypothetical research model.FindingsZero-Contact Marketing facilitates the positive impacts of Korean consumers' motivations (intrinsic and extrinsic) and service environment on their word-of-mouth (WOM) intention to spread information about a store offering Zero-Contact Marketing service and the store revisit intention. In addition, consumers' attitude toward Zero-Contact Marketing and shopping pleasure (SPL) has stronger impacts on consumers' WOM intention than they do on the store revisit intention.Research limitations/implicationsThe limitation of this study lies in that the survey participants responded only in South Korea, which may lead to biased results. To provide a more generalized insight, this study should be extended by considering consumers in other countries, since many consumers around the world tend to minimize face-to-face interaction and avoid unnecessary interruptions under the current pandemic.Practical implicationsBy minimizing the social interaction between employees and consumers, Zero-Contact Marketing may increase consumers' shopping satisfaction with free shopping moments and no disturbance, especially under the COVID-19 pandemic.Originality/valueThe findings provide theoretical contributions by empirically validating the effects of intrinsic and extrinsic motivations and service environment on consumers' internal and external responses in a Zero-Contact retail setting.

BACKGROUND: A high circulating concentration of interleukin 6 is associated with increased risk of coronary heart disease. Blockade of the interleukin-6 receptor (IL6R) with a monoclonal antibody (tocilizumab) licensed for treatment of rheumatoid arthritis reduces systemic and articular inflammation. However, whether IL6R blockade also reduces risk of coronary heart disease is unknown. METHODS: Applying the mendelian randomisation principle, we used single nucleotide polymorphisms (SNPs) in the gene IL6R to evaluate the likely efficacy and safety of IL6R inhibition for primary prevention of coronary heart disease. We compared genetic findings with the effects of tocilizumab reported in randomised trials in patients with rheumatoid arthritis. FINDINGS: In 40 studies including up to 133,449 individuals, an IL6R SNP (rs7529229) marking a non-synonymous IL6R variant (rs8192284; p.Asp358Ala) was associated with increased circulating log interleukin-6 concentration (increase per allele 9·45%, 95% CI 8·34-10·57) as well as reduced C-reactive protein (decrease per allele 8·35%, 95% CI 7·31-9·38) and fibrinogen concentrations (decrease per allele 0·85%, 95% CI 0·60-1·10). This pattern of effects was consistent with IL6R blockade from infusions of tocilizumab (4-8 mg/kg every 4 weeks) in patients with rheumatoid arthritis studied in randomised trials. In 25,458 coronary heart disease cases and 100,740 controls, the IL6R rs7529229 SNP was associated with a decreased odds of coronary heart disease events (per allele odds ratio 0·95, 95% CI 0·93-0·97, p=1·53×10(-5)). INTERPRETATION: On the basis of genetic evidence in human beings, IL6R signalling seems to have a causal role in development of coronary heart disease. IL6R blockade could provide a novel therapeutic approach to prevention of coronary heart disease that warrants testing in suitably powered randomised trials. Genetic studies in populations could be used more widely to help to validate and prioritise novel drug targets or to repurpose existing agents and targets for new therapeutic uses. FUNDING: UK Medical Research Council; British Heart Foundation; Rosetrees Trust; US National Heart, Lung, and Blood Institute; Du Pont Pharma; Chest, Heart and Stroke Scotland; Wellcome Trust; Coronary Thrombosis Trust; Northwick Park Institute for Medical Research; UCLH/UCL Comprehensive Medical Research Centre; US National Institute on Aging; Academy of Finland; Netherlands Organisation for Health Research and Development; SANCO; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Agentschap NL; European Commission; Swedish Heart-Lung Foundation; Swedish Research Council; Strategic Cardiovascular Programme of the Karolinska Institutet; Stockholm County Council; US National Institute of Neurological Disorders and Stroke; MedStar Health Research Institute; GlaxoSmithKline; Dutch Kidney Foundation; US National Institutes of Health; Netherlands Interuniversity Cardiology Institute of the Netherlands; Diabetes UK; European Union Seventh Framework Programme; National Institute for Healthy Ageing; Cancer Research UK; MacArthur Foundation.